M. Okada

Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.

M. Matsuda, K. Kaku, M. Eto, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy.

M. Eto, M. Nomura, M. Saito, 1995, Clinical genetics.

A case of type 2 diabetes with a large abscess of the gastric wall successfully treated with a glycemic control and systemic antibiotics.

M. Haneda, M. Okada, Y. Iwashima, 2005, Diabetes research and clinical practice.

Increased frequency of apolipoprotein ε2 allele in non‐insulin dependent diabetic (NIDDM) patients with nephropathy

I. Makino, M. Eto, M. Nomura, 1995 .

Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan

M. Sakurai, S. Ueda, S. Hiramitsu, 2022, BMJ Open.

Regression of cardiac hypertrophy in type 2 diabetes with hypertension by candesartan.

M. Haneda, M. Okada, Y. Iwashima, 2006, Diabetes research and clinical practice.

The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

M. Sakurai, S. Ueda, S. Hiramitsu, 2023, Frontiers in Cardiovascular Medicine.

Remnant-like particles (RLP) from NIDDM patients with apolipoprotein E3/3 phenotype stimulate cholesteryl ester synthesis in human monocyte-derived macrophages.

I. Makino, M. Eto, M. Saito, 1996, Artery.